Literature DB >> 11358796

AIB1 enhances estrogen-dependent induction of cyclin D1 expression.

M D Planas-Silva1, Y Shang, J L Donaher, M Brown, R A Weinberg.   

Abstract

AIB1 was isolated as a gene amplified in breast cancer and encodes a protein that acts as a steroid receptor coactivator. The role of steroid receptor coactivators such as AIB1 in breast cancer development is not clear. It is possible that AIB1 cooperates with estrogen receptor alpha in regulating estrogen-dependent cell proliferation. Ectopic expression of the estrogen receptor alpha in different cell lines does not confer estrogen-induced proliferation. This inability of the estrogen receptor to drive proliferation has been recently correlated with a lack of estrogen-dependent cyclin D1 expression in cells engineered to express the estrogen receptor. In this study, we evaluated whether high levels of AIB1 enable the estrogen receptor to direct the transcription of cyclin D1. We show here that AIB1 and other steroid receptor coactivators can enhance the functional interaction of the estrogen receptor with the cyclin D1 promoter. Increases of AIB1 levels in breast cancer cells by amplification and/or overexpression may represent one way to confer estrogen-dependent mitogenic stimulation to breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11358796

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  38 in total

1.  Cell cycle-dependent expression of thyroid hormone receptor-beta is a mechanism for variable hormone sensitivity.

Authors:  Padma Maruvada; Natalia I Dmitrieva; Joyce East-Palmer; Paul M Yen
Journal:  Mol Biol Cell       Date:  2004-02-06       Impact factor: 4.138

2.  Bip is a molecular link between the phase I and phase II estrogenic responses in uterus.

Authors:  Sanhita Ray; Xiaonan Hou; Han-E Zhou; Haibin Wang; Sanjoy K Das
Journal:  Mol Endocrinol       Date:  2006-03-30

3.  Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA.

Authors:  Anwar Hossain; Macus T Kuo; Grady F Saunders
Journal:  Mol Cell Biol       Date:  2006-08-28       Impact factor: 4.272

4.  Functional interactions between the estrogen receptor coactivator PELP1/MNAR and retinoblastoma protein.

Authors:  Seetharaman Balasenthil; Ratna K Vadlamudi
Journal:  J Biol Chem       Date:  2003-04-07       Impact factor: 5.157

5.  Regulation of hormonal therapy resistance by cell cycle machinery.

Authors:  Binoj Chandrasekharan Nair; Ratna K Vadlamudi
Journal:  Gene Ther Mol Biol       Date:  2008-01-01

6.  Generation and validation of a mouse line with a floxed SRC-3/AIB1 allele for conditional knockout.

Authors:  Zhaoliang Liu; Lan Liao; Suoling Zhou; Jianming Xu
Journal:  Int J Biol Sci       Date:  2008-07-23       Impact factor: 6.580

Review 7.  Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family.

Authors:  Jianming Xu; Ray-Chang Wu; Bert W O'Malley
Journal:  Nat Rev Cancer       Date:  2009-09       Impact factor: 60.716

Review 8.  The Role of Steroid Receptor Coactivators in Hormone Dependent Cancers and Their Potential as Therapeutic Targets.

Authors:  Lei Wang; David M Lonard; Bert W O'Malley
Journal:  Horm Cancer       Date:  2016-04-28       Impact factor: 3.869

9.  Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter.

Authors:  Luigi Cicatiello; Raffaele Addeo; Annarita Sasso; Lucia Altucci; Valeria Belsito Petrizzi; Raphaelle Borgo; Massimo Cancemi; Simona Caporali; Silvana Caristi; Claudio Scafoglio; Diana Teti; Francesco Bresciani; Bruno Perillo; Alessandro Weisz
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

10.  Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation.

Authors:  Shu Wang; Yuhui Yuan; Lan Liao; Shao-Qing Kuang; Jean Ching-Yi Tien; Bert W O'Malley; Jianming Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.